BOSTON SCIENTIFIC CORP is 1.5x more valuable than Medline Inc. by market capitalization ($71.85 B vs $49.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BSX | MDLN |
|---|---|---|
| Market cap | $71.85 B | $49.12 B |
| US-listed rank | #236 | #322 |
| Revenue (latest FY) | $20.07B | $28.43B |
| Net income (latest FY) | - | $1.16T |
| Net margin | - | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 1,009 | 103 |
BOSTON SCIENTIFIC CORP is 1.5x more valuable than Medline Inc. by market capitalization ($71.85 B vs $49.12 B).
In their latest fiscal years, BOSTON SCIENTIFIC CORP reported $20.07B in revenue while Medline Inc. reported $28.43B.
Full pages: BOSTON SCIENTIFIC CORP and Medline Inc., or browse the full rankings.